Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Quick Stats
Jul 02, 202664.2
AI Score
BUY1.05
Volume Ratio
Aug 04, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
ADPT Stock Summary
Last updated Jul 02, 2026
ADPT is currently trading at $21.19, positioned above its 200-day moving average of $15.79, indicating a long-term uptrend. The stock has a 52-week range of $9.9551 to $22.8.
Technical Analysis: The 50-day moving average stands at $15.9, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 67.376, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.142, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ADPT at 64.2/100 with a BUY recommendation.
ADPT (Adaptive Biotechnologies Corporation Common Stock) Indicators
Last updated Jul 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 67.376 |
| CMF (20) | 0.142 |
| ROC (10) | 26.281 |
| ADX (14) | 44.804 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.659 |
| AROONOSC (14) | 78.571 |
| WILLAMS %R (14) | -23.333 |
| MFI (14) | 46.83 |
ADPT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ADPT Price vs Max Options Open Interest
ADPT Max Change In Options Open Interest
ADPT Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADPT Daily Out of Money Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADPT Daily In the Money Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADPT Most Active Options by Volume(near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Adaptive Biotechnologies Corporation Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
ADPT Moving Averages Analysis
Adaptive Biotechnologies Corporation Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 02, 2026
Adaptive Biotechnologies Corporation Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 02, 2026
ADPT (Adaptive Biotechnologies Corporation Common Stock) Simple Moving Averages
Moving Averages are last updated Jul 02, 2026
| Days | MA |
|---|---|
| 10 | 19.91 |
| 20 | 18.65 |
| 30 | 17.31 |
| 50 | 15.9 |
| 100 | 15.26 |
| 200 | 15.79 |
ADPT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.6 billion |
| Earnings/Share ($) | -0.32 |
| Net Proft Margin (%) | -0.1682 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.4573 |
| EPS Estimate Next Year ($) | -0.2529 |
| WallStreet Target Price ($) | 20.2857 |
| Most Recent Quarter |